CLL cases with low levels of the cell surface SLAMF1/CD150 expression in B cells are characterized by high levels of sSLAMF1/CD150 in blood plasma in contrast to CLL cases with high cell surface SLAMF1/CD150 expression in B cells. Here, SLAMF1 is linked to B-cell chronic lymphocytic leukemia.